Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

This publication has 47 references indexed in Scilit:

• Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
  Cerebrovascular Diseases, 2003
• Utility of TICS‐M for the assessment of cognitive function in older adults
  International Journal of Geriatric Psychiatry, 2003
• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic Attack
  Stroke, 1999
• Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
  The American Journal of Cardiology, 1995
• Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project
  Stroke, 1995
• Interobserver agreement for the assessment of handicap in stroke patients.
  Stroke, 1989
• Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial
  New England Journal of Medicine, 1989
• Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort
  Journal of Chronic Diseases, 1984